Medicared For All Logo

Emad Alatassi MD in Roseville, Michigan

Home Michigan Roseville

Emad Alatassi MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 18263 E 10 Mile Rd D in Roseville, Michigan. There is an additional office location, for a total of two, for Emad Alatassi MD that can be viewed further down.

They're a part of the: Emad Alatassi Md, P.c. medical group which has around 2 members. You can call their office at 586-238-2059 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are listed as doing telehealth appointments.


Emad Al Alatassi MD Office Phone and Directions

Emad Alatassi MD
Emad Alatassi Md, P.c.
18263 E 10 Mile Rd D
Roseville, Michigan 48066
586-238-2059


Patient Ratings
Please rate your experience with Emad Alatassi MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 586-238-2059


Enter a starting address:


Healthcare Info for Emad Alatassi MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Emad Alatassi MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 6507829678
NPI #: 1528018256
NPI Created On: 05/11/2006
NPI Last Updated Listed as: 11/04/2019
Primary Taxonomy Code: 207LC0200X
License Number:
4301069292
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Molina Healthcare of Michigan, Inc.
  • Humana
  • Total Health Care USA, Inc.
  • McLaren Health Plan Community
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.


Services and Procedures include:

  1. Ventilation assistance and management, nursing facility per day
  2. Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
  3. Sleep monitoring of patient (6 years or older) in sleep lab
  4. Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
  5. New patient office or other outpatient visit, typically 30 minutes
  6. New patient office or other outpatient visit, typically 30 minutes
  7. New patient office or other outpatient visit, typically 45 minutes
  8. Established patient office or other outpatient visit, typically 15 minutes
  9. Established patient office or other outpatient, visit typically 25 minutes
  10. Initial hospital inpatient care, typically 50 minutes per day
  11. Subsequent hospital inpatient care, typically 25 minutes per day
  12. Subsequent hospital inpatient care, typically 35 minutes per day
  13. Physician telephone patient service, 11-20 minutes of medical discussion
  14. Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788346735

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30


Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801701261

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801701879

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801703481

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801908691

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801920581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801979517

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802141689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802227121

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802232609

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Additional Office Locations

1. Beaumont Medical Group- Specialty Services
25631 Little Mack Ave
Saint Clair Shores, MI 48081
Suite 203
Group Members: 800

Phone: 586-238-2059

Enter a starting address:


Pulmonary Disease Professionals in Roseville

18263 E 10 Mile Rd D
Roseville, MI

18263 E 10 Mile Rd D
Roseville, MI
Emad Alatassi Md, P.c.

18263 E 10 Mile Rd
Roseville, MI

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

25250 Kelly Rd
Roseville, MI
Beaumont Medical Group- Specialty Services

Providers in Emad Alatassi Md, P.c.

1.Emad Alatassi Md

18263 E 10 Mile Rd D
Roseville Mi 48066-5805
Emad Alatassi Md, P.c.
Pulmonary Disease

2.Fadi-jean Saad Md

18263 E 10 Mile Rd D
Roseville Mi 48066-5805
Emad Alatassi Md, P.c.
Pulmonary Disease

View all 2 members of Emad Alatassi Md, P.c. medical group